2 min readThe Federal Reserve held its last meeting of the year this week and to no one’s surprise, it left the overnight lending rate unchanged at the 0.00% to 0.25% range. As it wraps up a tumultuous 2020 and looks forward to the new year, the Fed is focused on supporting “the U.S. economy in this…
1 min readIn this webinar, Stefan Spazek, along with a panel of lenders review the ups and downs of 2020 while also looking ahead to what the coming year may bring. Watch a recording (12/8/2020) of Capital Advisors Group’s webinar, Venture Debt – A 2020 Retrospective And A Look Ahead. Hosted by Stefan Spazek, EVP – Director…
2 min readOutgoing Treasury Secretary Mnuchin announced in late November that he would allow certain Federal Reserve relief programs to expire at the end of the year. Federal Reserve officials had publicly urged Mnuchin to extend all emergency programs but ultimately conceded and will close several of the facilities this month. The Fed also announced on Monday…
2 min readVaccine Progress Earlier this month, Pfizer and BioNTech announced that their COVID-19 vaccine proved to be more than 90% effective in early trial results, while Moderna reported that its version is 95% effective in protecting patients from the virus. Fed Chair Jerome Powell spoke with Bank of England governor Andrew Bailey and European Central Bank…
5 min readThe 2020 election was an arduous and, in some ways, incredible process, with the unprecedented number of mail-in ballots resulting in record turnout, but also a significant delay in announcing the winner. Nevertheless, we know that Joe Biden will be the next President of the United States come January. In all likelihood he will face…
5 min readThe old adage in corporate debt financing is “The best time to borrow is when you need it the least.” But the concept of timing when it comes to debt financing can take many different forms. This blog post intends to address some of the potential timing issues around debt financing and where and how…
6 min readWith 48 potential SARS-CoV-2 vaccines now undergoing clinical trials on humans, there’s mounting hope that one or more will be available in 2021. But many unknowns remain, especially regarding potential financial implications for the pharmaceutical companies that produce them. Timing of their arrival, manufacturing capacity, distribution, levels of potential government support, overall costs, and final…
2 min readA Momentous Week All eyes are on the United States as Election Day finally arrives and a bitterly contentious campaign cycle draws to a close. An estimated 100 million early votes were cast in advance of Election Day and the country appears to be heading for a record presidential election turnout. The focus now shifts…
2 min readInflation & Employment Readings on consumer inflation this week remained tame overall with wide variance around the average for certain components. CPI for September was up just 1.4% year-over-year and Core CPI was up 1.7% year-over-year. Weekly Initial Jobless Claims remain high at nearly 900,000 in the week ended October 10. Surging COVID-19 infection rates…
2 min readFed officials are committed to the current level of rates until inflation exceeds 2% Several Fed officials spoke in late September on the timing of future interest rate hikes in relation to the inflation target of 2%. Chicago Fed President Evans reversed his earlier position that the Fed could start raising rates before inflation reaches…